Product Images Abacavir And Lamivudine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Abacavir And Lamivudine NDC 65862-335 by Aurobindo Pharma Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL – 600 mg/300 mg (30 Tablets Container) - abalami fig1

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL – 600 mg/300 mg (30 Tablets Container) - abalami fig1

This is a description of a medicine named Abacavir and Lamivudine Tablets USP which includes 600 mg of abacavir and 300 mg of lamivudine. Each tablet is film-coated and contains FD&C Yellow No.6 color additive in it. The usual dosage information is not available; however, it is advised to see the prescribing information for dosage and administration. The medication is distributed by Aurabindo Pharma USA, Inc. and the batch code is TS/DRUGS/19/1993. The tablets should be stored at room temperature within 15-30°C (59° to 86°F). Each time the tablets are dispensed, it is important to give the patient a Medication Guide and Warning Card from the carton.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL – 600 mg/300 mg (30 Tablets Container Carton) - abalami fig2

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL – 600 mg/300 mg (30 Tablets Container Carton) - abalami fig2

Abacavir and Lamivudine tablets are a prescription medicine used to treat HIV-1 infection. This medication contains Abacavir sulfate USP equivalent to abacavir 600 mg and lamivudine USP 300 mg. It is advised to read the prescribing information before using the medicine. The tablets should be stored at 20-25°C with excursions permitted to 15-30°C. The medication should be given with a medication guide and warning card from the carton. Distributed by Aurobindo Pharma USA, Inc.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL – 600 mg/300 mg (100 Unit-dose Tablets (10 x 10s)) - abalami fig3

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL – 600 mg/300 mg (100 Unit-dose Tablets (10 x 10s)) - abalami fig3

Abacavir and Lamivudine Tablets USP containing Abacavir sulfate USP equivalent to abacavir 600 mg and lamivudine USP 300 mg in each film-coated tablet are available as 100 unit-dose tablets (10 x 10s). These tablets are meant for oral administration and are distributed by Aurobindo Pharma USA, Inc. Each time Abacavir and Lamivudine Tablets USP are dispensed, the patient must be given a Medication Guide and Warning Card from the carton. The usual dosage for these tablets is mentioned in the prescribing information that comes with the tablets. The tablets contain FD&C Yellow No. 6 as a color additive and must be stored at 20° to 25°C (68° to 77°F); excursions permitted to 15° t0 30°C (59° to 86°F) [see USP Controlled Room Temperature]. The given text does not have a clear context and can be used as a general description of Abacavir and Lamivudine Tablets USP.*

Abacavir Sulfate Structure - abalami str1

Abacavir Sulfate Structure - abalami str1

Lamivudine Structure - abalami str2

Lamivudine Structure - abalami str2

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.